Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43219 | 0.90 | — | — | |
| Ether SCHEMBL11500475 | 0.89 | MEN1 (0.40) | MEN1POLBKMT2AALDH1A1CA1 | |
| Ether SCHEMBL4458913 | 0.89 | ALDH1A1 (0.42) | MEN1POLBKMT2AALDH1A1CA1 | |
| Ether SCHEMBL8954038 | 0.88 | POLB (0.54) | MEN1POLBKMT2AALDH1A1CA1 | |
| Hydrochloric Acid SCHEMBL15310751 | 0.88 | — | — | |
| SCHEMBL943794 | 0.88 | — | — | |
| Water SCHEMBL27992209 | 0.88 | MEN1 (0.46) | MEN1POLBKMT2AALDH1A1CA1 | |
| Water SCHEMBL27297843 | 0.88 | — | — | |
| Propane SCHEMBL892321 | 0.87 | MEN1 (0.50) | MEN1POLBKMT2AALDH1A1CA1 | |
| Ether SCHEMBL6703712 | 0.85 | POLB (0.38) | MEN1POLBKMT2AALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106633067-A | New method for preparing allyl ether modified silicone oil | 杭州铂聚科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| CN-105473567-A | Formation of chromanes and chromenes by using silver(i) or gold(i) salts or complexes | DSM IP ASSETS BV | 2016-04-06 | — | — | CN | claimed |
| US-9085525-B2 | Processes employing cyclodextrin derivative quaternary salts | MATOS JOSE R (US) | 2015-07-21 | — | — | US | claimed |
| US-20140046061-A1 | Processes Employing Cyclodextrin Derivative Quaternary Salts | MATOS JOSE R (US) | 2014-02-13 | — | — | US | claimed |
| US-8492538-B1 | Cyclodextrin derivative salts | MATOS JOSE R (US) | 2013-07-23 | — | — | US | claimed |
| CN-117500845-A | Prediction apparatus, manufacturing apparatus, and prediction method | 大金工业株式会社 | 2024-02-02 | — | — | CN | disclosed |
| US-20230075719-A1 | AQUEOUS ENERGY CURABLE INKJET INKS | KAO CORPORATION (JP) | 2023-03-09 | — | — | US | disclosed |
| CN-109844641-B | Environmentally stable thick film chemically amplified resists | 默克专利有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-114929812-A | Aqueous energy curable inkjet inks | 花王株式会社 | 2022-08-19 | — | — | CN | disclosed |
| US-11385543-B2 | Enviromentally stable, thick film, chemically amplified resist | MERCK PATENT GMBH (DE) | 2022-07-12 | — | — | US | disclosed |
| US-11254638-B2 | Nitrileoxide compound | DAIKIN INDUSTRIES, LTD. (JP) | 2022-02-22 | — | — | US | disclosed |
| CN-108472237-B | Mascara compositions and methods | ELC 管理有限责任公司 | 2021-12-28 | — | — | CN | disclosed |
| US-20030019756-A1 | Reaction is executed in a reaction vessel containing matter in a supercritical or subcritical state and an electrolytic solution; free of generated liquid waste, no need to clean the electrode | MIYATA, SEIZO (JP) | 2003-01-30 | — | — | US | disclosed |
| EP-1003734-A2 | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST | Merck & Co., Inc. (US) | 2000-05-31 | — | — | EP | disclosed |
| US-5908664-A | USING SYNTHETIC LIQUID DETERGENT DURING PRESS WORKING | NAGAYAMA ELECTRONIC INDUSTRY CO., LTD. (JP) | 1999-06-01 | — | — | US | disclosed |
| WO-1999007695-A2 | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST | MERCK & CO., INC. (US) | 1999-02-18 | — | — | WO | disclosed |
| US-RE35773-E | SILOXANE-ADDITION POLYMER COMPOSITE | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-04-21 | — | — | US | disclosed |
| US-4775778-A | POSITIVE TEMPERATURE COEFFICIENT-CROSSLINKED ELASTOMER AND ELECTROCONDUCTIVE PARTICLES | RAYCHEM CORPORATION (US) | 1988-10-04 | — | — | US | disclosed |
| US-4534889-A | PTC Compositions and devices comprising them | RAYCHEM CORPORATION (US) | 1985-08-13 | — | — | US | disclosed |
| US-4496768-A | USING RHODIUM COMPLEX CATALYST WITH CARBON MONOXIDE AND CYCLIC PHOSPHITE | DAVY MCKEE LIMITED (GB) | 1985-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254638-B2 | Nitrileoxide compound | NOS3, NOS2, NOS1 | MEN1 1226/4885POLB 1523/4885KMT2A 2530/4885 |
| US-20140046061-A1 | Processes Employing Cyclodextrin Derivative Quaternary Salts | PICALM, SI, PDCD2L | MEN1 3715/4885POLB 1354/4885KMT2A 3677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.